Abstract
Background: Endocannabinoid system (ECS) via cannabinoid (CB: CB1 and CB2) receptors and enzymes degrading endocannabinoids in the brain (atty-acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), plays a key role in regulation of mood and anxiety. However, the effects of cannabinoid compounds on anxiety-related responses is complex and yield mixed results depending on the type of pharmacological manipulation (direct or indirect) of functions of ECS, as well as kind of cannabinoids, dosage and procedure. Methods: The aim of the study was to determine and compare the influence of the direct (via CB receptors ligands) and indirect (via inhibition of enzymes degrading endocannabinoids in the brain) pharmacological modulation of ECS function on the anxiety-like responses in mice in the elevated plus maze (EPM) test. For this purpose, in the first step of experiments we used selected ligands of CB1, CB1/CB2 and CB2 receptors to asses which type of CB receptors is involved in the anxiety-related responses in mice. Next, we used inhibitors of FAAH or MAGL to assess which enzyme is more responsible for anxiety-related behavior in mice. Results: The results of our presented research showed that an acute administration of CB1 receptor agonist – oleamide (5-20 mg/kg) had no influence on anxiety-related responses and CB1 receptor antagonist – AM 251 had anxiogenic (0.25-3 mg/kg) effects in the EPM test in mice. In turn, an acute administration of CB1/CB2 receptor agonist - WIN55,212-2 used at a dose of 1 mg/kg, had an anxiolytic effect observed in mice in the EPM test. What is of interest, both acute administration of CB2 receptor agonist (JWH 133 at the doses of 1 and 2 mg/kg) and antagonist (AM 630 at the doses of 0.5-2 mg/kg) had anxiogenic effects in this procedure. Moreover, we revealed that an acute administration of only FAAH inhibitor - URB 597 (0.3 mg/kg) had anxiolytic effect, while MAGL inhibitor (JZL 184) after an acute injection had no influence on anxiety behavior in mice observed in the EPM. Conclusion: In our experiments we confirmed the significant involvement of the ECS in anxiety-related responses. Both pharmacological indirect and direct (mainly through the CB1 receptors) manipulation of ECS functions is able to elicit promising anxiolytic effects. Therefore, ECS could be a potential target for novel anxiolytic drugs; however the further studies are needed.
All Related Versions

This publication has 79 references indexed in Scilit: